Cytokines in pathogenesis of peri-implantitis;Uloga citokina u patogenezi periimplantitisa

Vojnosanitetski Pregled

Volumn 68, Issue 5, 2011, Pages 435-440

  Petković Ćurčin, Aleksandra ^a   Matić, Smiljana ^a   Vojvodić, Danilo ^a   Stamatović, Novak ^a   Todorović, Tatjana ^b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cytokines; Dental implants; Inflammation; Inflammation mediators; Risk factors

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; BODY FLUID; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CYTOKINE PRODUCTION; GRAM NEGATIVE BACTERIUM; HUMAN; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; MOUTH FLORA; OSTEOLYSIS; PERI IMPLANT FLUID; PERIIMPLANTITIS; PERIODONTITIS; RISK FACTOR; SPIROCHETE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; TOOTH PLAQUE;

BIOCOMPATIBLE MATERIALS; CYTOKINES; DENTAL IMPLANTATION, ENDOSSEOUS; HUMANS; INFLAMMATION MEDIATORS; PERI-IMPLANTITIS; RISK FACTORS;

EID: 79957584157     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1105435P     Document Type: Article

References (32)

1. Perović J. Oral implantology. Belgrade: Tekom; 2001. (Serbian)
2. Matić S, Stamatović N. Elements of oral implantology. Belgrade: Vojna štamparija, 2008. (Serbian)
3. Block MS. Hard and soft tissue grafting for aesthetic implant restorations. In: Babbush CA, editor. Dental implants: the art and science. Philadelphia, PA: WB Saunders Co; 2001. p. 201-16.
4. Teles RP, Haffajee AD, Socransky SS. Peri-implant infections. Clinical periodontology and implant dentistry. 5th ed. Oxford: Blackwell Munksgaard; 2008. p. 268-77.
5. Becker W, Becker BE, Newman MG, Nyman S. Clinical and microbiologic findings that may contribute to dental implant failure. Int J Oral Maxillofac Implants 1990; 5(1): 31-8.
6. Esposito M, Hirsch J, Lekholm U, Thomsen P. Differential diagnosis and treatment strategies for biologic complications and failing oral implants: a review of the literature. Int J Oral Maxillofac Implants 1999; 14(4): 473-90.
7. Berglundh T, Lindhe J, Lang NP. Peri-implant mucositis and peri-implantitis. Clinical periodontology and implant dentistry. 5th ed. Oxford: Blackwell Munksgaard; 2008. p. 529-38.
8. Listgarten MA. Microorganisms and dental implants. J Periodontol 1999; 70(2): 220-2.
9. Mombelli A, Lang NP. Clinical parameters for the evaluation of dental implants. Periodontol 2000. 1994; 4: 81-6.
10. Weber HP, Cochran DL. The soft tissue response to osseointegrated dental implants. J Prosthet Dent 1998; 79(1): 79-89.
11. Oppenheim JJ, Ruscetti FW, Faltynek C. Cytokines. In: Stites DP, Terr AI, editors. Basic and Clinical Immunology. 8th ed. Connecticut: Appleton and Lange; 1994. p. 105-23.
12. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998; 9(3): 248-66.
13. Carrannza FA, Bulkacz J. Defense mechanism of the gingiva. In: Carranza FA, Newman MG, editors. Clinical periodontology. 8th ed. Philadelphia, PA: WB Saunders Co; 1996.
14. Uitto VJ. Gingival crevice fluid - an introduction. Periodontol 2000 2003; 31: 9-11.
15. Page RC, Kornman KS. The pathogenesis of human periodontitis: An introduction. Periodontol 2000 1997; 14(1): 9-11.
16. Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodontal Res 1993; 28(6 Pt 2): 478-86.
17. Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994; 5: 112-41.
18. Dennison DK, Van Dyke TE. The acute inflammatory response and the role of phagocytic cells in periodontal health and disease. Periodontol 2000 1997; 14(1): 54-78
19. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008; 79(8 Suppl): 1585-91.
20. Huang GT, Haake SK, Park NH. Gingival epithelial cells increase interleukin-8 secretion in response to Actinobacillus actinomycetemcomitans challenge. J Periodontol 1998; 69(10): 1105-10.
21. Petković A. Significance of proinflammatory (IL1β, TNFα, MIP1α i IL8) and peri-implant sulcus fluid [thesis]. Belgrade: Military Medical Academy; 2005. (Serbian)
22. Panagakos FS, Aboyoussef H, Dondero R, Jandinski JJ. Detection and measurement of inflammatory cytokines in implant crevicular fluid: a pilot study. Int J Oral Maxillofac Implants 1996; 11(6): 794-9.
23. Salcetti JM, Moriarty JD, Cooper LF, Smith FW, Collins JG, Socransky SS, et al. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofac Implants 1997; 12(1): 32-42.
24. Curtis DA, Kao RT, Plesh O, Finzen F, Franz L. Crevicular fluid alalysis around two failing dental implants: a clinical report. J. Prosthodont 1997; 6(3): 210-4.
25. Kao RT, Curtis DA, Richards DW, Preble J. Increased interleukin- 1 beta in the crevicular fluid of diseased implants. Int J Oral Maxillofac Implants 1995; 10(6): 696-701.
26. Ataoglu H, Alptekin NO, Haliloglu S, Gursel M, Ataoglu T, Serpek B, et al. Interleukin-1beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crevicular fluid. Clin Oral Implants Res 2002; 13(5): 470-6.
27. Delima AJ, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S, et al. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol 2001; 28(3): 233-40.
28. Aboyoussef H, Carter C, Jandinski JJ, Panagakos FS. Detection of prostaglandin E2 and matriks metalloproteinases in implant crevicular fluid. Int J Oral Maxillofac Implants 1998; 13(5): 689-96.
29. Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y, et al. Osteocalcin, deoxypyridinoline and interleukin-1beta in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res 2002; 13(6): 637-43.
30. Johnson RB, Wood N, Serio FG. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol 2004; 75(1): 37-43.
31. Machtei EE, Oved-Peleg E, Peled M. Comparison of clinical, radiographic and immunological parameters of teeth and different dental implant platforms. Clin Oral Implants Res 2006; 17(6): 658-65.
32. de Mendonça AC, Santos VR, César-Neto JB, Duarte PM. Tumor necrosis factor-alpha levels after surgical anti-infective mechanical therapy for peri-implantitis: a 12-month follow-up. J Periodontol 2009; 80(4): 693-9.